PrairieView Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
PrairieView Partners's PFE Position: Q2 2025 in Review
PrairieView Partners reduced its Pfizer (PFE) stake by 38% in Q2 2025, selling an estimated $27.9K and leaving 1,964 shares worth $47K. The position accounts for ﹤0.01% of the portfolio, ranked #193.
PrairieView Partners first reported a position in PFE in Q4 2017 and has held it in 26 quarters since. The position peaked at $319K in Q4 2021. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.
- PrairieView Partners held 1,964 shares of Pfizer worth $47K as of Q2 2025.
- PrairieView Partners sold 1,195 Pfizer shares in Q2 2025, an estimated $27.9K.
- Pfizer made up ﹤0.01% of PrairieView Partners's portfolio in Q2 2025, its #193 holding.
- PrairieView Partners first reported a position in Pfizer in Q4 2017 and has held it in 26 quarters since.
- PrairieView Partners's Pfizer position peaked at $319K in Q4 2021.
- 2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.
Based on PrairieView Partners's 13F filing for Q2 2025, filed 25 Jul 2025.